Dossier
Capricor
Coverage of Capricor in the Nexus archive.
- Capricor’s data clash and a fugitive in the C-suite
The article discusses the FDA's inconsistent approaches to Duchenne muscular dystrophy drugs, potential changes in drug company leadership, and Adam's conversation with a recruiter. It references a podcast episode exploring these topics.